239 related articles for article (PubMed ID: 20068069)
41. Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer.
Shiota M; Zoubeidi A; Kumano M; Beraldi E; Naito S; Nelson CC; Sorensen PH; Gleave ME
Mol Cancer Res; 2011 Dec; 9(12):1755-66. PubMed ID: 21987172
[TBL] [Abstract][Full Text] [Related]
42. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
[TBL] [Abstract][Full Text] [Related]
43. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
[TBL] [Abstract][Full Text] [Related]
44. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
[TBL] [Abstract][Full Text] [Related]
45. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.
Mu L; Yang F; Guo D; Li P; Zhang M
Bioengineered; 2020 Dec; 11(1):472-483. PubMed ID: 32250192
[TBL] [Abstract][Full Text] [Related]
47. Characterization of COMMD protein-protein interactions in NF-kappaB signalling.
de Bie P; van de Sluis B; Burstein E; Duran KJ; Berger R; Duckett CS; Wijmenga C; Klomp LW
Biochem J; 2006 Aug; 398(1):63-71. PubMed ID: 16573520
[TBL] [Abstract][Full Text] [Related]
48. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y cells.
Carreras I; Garrett-Young R; Ullman MD; Eisenhauer PB; Fine RE; Wells JM; Conn KJ
J Neurosci Res; 2005 Feb; 79(4):495-502. PubMed ID: 15635600
[TBL] [Abstract][Full Text] [Related]
50. Silencing of secretory clusterin sensitizes NSCLC cells to V-ATPase inhibitors by downregulating survivin.
Kim YS; Jin HO; Hong SE; Song JY; Hwang CS; Park IC
Biochem Biophys Res Commun; 2018 Jan; 495(2):2004-2009. PubMed ID: 29253572
[TBL] [Abstract][Full Text] [Related]
51. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
Li N; Zoubeidi A; Beraldi E; Gleave ME
Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
[TBL] [Abstract][Full Text] [Related]
52. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
53. A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction.
Sahu I; Sangith N; Ramteke M; Gadre R; Venkatraman P
FEBS J; 2014 Jun; 281(11):2688-709. PubMed ID: 24720748
[TBL] [Abstract][Full Text] [Related]
54. COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.
Taura M; Kudo E; Kariya R; Goto H; Matsuda K; Hattori S; Vaeteewoottacharn K; McDonald F; Suico MA; Shuto T; Kai H; Okada S
J Virol; 2015 Mar; 89(5):2643-58. PubMed ID: 25520503
[TBL] [Abstract][Full Text] [Related]
55. Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.
Muramaki M; So A; Hayashi N; Sowery R; Miyake H; Fujisawa M; Gleave ME
BJU Int; 2009 Feb; 103(3):384-90. PubMed ID: 19007378
[TBL] [Abstract][Full Text] [Related]
56. TRAF-interacting protein with forkhead-associated domain (TIFA) transduces DNA damage-induced activation of NF-κB.
Fu J; Huang D; Yuan F; Xie N; Li Q; Sun X; Zhou X; Li G; Tong T; Zhang Y
J Biol Chem; 2018 May; 293(19):7268-7280. PubMed ID: 29581234
[TBL] [Abstract][Full Text] [Related]
57. Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination.
Geng H; Wittwer T; Dittrich-Breiholz O; Kracht M; Schmitz ML
EMBO Rep; 2009 Apr; 10(4):381-6. PubMed ID: 19270718
[TBL] [Abstract][Full Text] [Related]
58. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
Zhang B; Liu ZM; Hao FG; Wang M
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
[TBL] [Abstract][Full Text] [Related]
59. Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo.
So A; Sinnemann S; Huntsman D; Fazli L; Gleave M
Mol Cancer Ther; 2005 Dec; 4(12):1837-49. PubMed ID: 16373699
[TBL] [Abstract][Full Text] [Related]
60. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.
Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH
J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
